Lianbo Gao

1.4k total citations
10 papers, 186 citations indexed

About

Lianbo Gao is a scholar working on Epidemiology, Molecular Biology and Neurology. According to data from OpenAlex, Lianbo Gao has authored 10 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Lianbo Gao's work include Acute Ischemic Stroke Management (4 papers), Cerebrovascular and Carotid Artery Diseases (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Lianbo Gao is often cited by papers focused on Acute Ischemic Stroke Management (4 papers), Cerebrovascular and Carotid Artery Diseases (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Lianbo Gao collaborates with scholars based in China. Lianbo Gao's co-authors include Zhongrong Miao, Hongbo Zheng, Yilong Wang, Tie‐Yan Liu, Qiyi Zhu, Kangning Chen, Feng Wang, Yongjun Wang, Jie Shuai and Yongli Li and has published in prestigious journals such as Stroke, International Journal of Nanomedicine and Frontiers in Bioengineering and Biotechnology.

In The Last Decade

Lianbo Gao

10 papers receiving 185 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianbo Gao China 6 123 101 88 21 20 10 186
Sherita Chapman United States 6 94 0.8× 20 0.2× 35 0.4× 22 1.0× 36 1.8× 20 200
Congguo Yin China 7 134 1.1× 53 0.5× 46 0.5× 57 2.7× 32 1.6× 20 182
Yu Cui China 9 141 1.1× 50 0.5× 69 0.8× 33 1.6× 28 1.4× 51 226
Håkon Tobro Norway 3 144 1.2× 37 0.4× 33 0.4× 45 2.1× 27 1.4× 3 158
Hui-Sheng Chen China 5 132 1.1× 45 0.4× 28 0.3× 33 1.6× 37 1.9× 11 196
Wenhuo Chen China 9 256 2.1× 157 1.6× 97 1.1× 77 3.7× 11 0.6× 41 290
Andrew Douglas Ireland 6 83 0.7× 55 0.5× 14 0.2× 41 2.0× 17 0.8× 12 121
Hongjian Shen China 7 79 0.6× 57 0.6× 33 0.4× 24 1.1× 8 0.4× 26 121
Véronique Dubuc Canada 4 128 1.0× 66 0.7× 47 0.5× 25 1.2× 17 0.8× 6 163
Zhonglun Chen China 9 81 0.7× 46 0.5× 42 0.5× 15 0.7× 21 1.1× 16 125

Countries citing papers authored by Lianbo Gao

Since Specialization
Citations

This map shows the geographic impact of Lianbo Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianbo Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianbo Gao more than expected).

Fields of papers citing papers by Lianbo Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianbo Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianbo Gao. The network helps show where Lianbo Gao may publish in the future.

Co-authorship network of co-authors of Lianbo Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Lianbo Gao. A scholar is included among the top collaborators of Lianbo Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianbo Gao. Lianbo Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Meitong, Jiuhan Zhao, Lianbo Gao, et al.. (2025). Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson’s disease. Biological Research. 58(1). 7–7. 5 indexed citations
3.
Yu, Jiachen, Rong Ran, Duoyi Zhao, et al.. (2024). Research Progress in the Field of Tumor Model Construction Using Bioprinting: A Review. International Journal of Nanomedicine. Volume 19. 6547–6575. 1 indexed citations
4.
Yu, Jiachen, Yuting Liu, Rong Ran, et al.. (2024). Smart nanogels for cancer treatment from the perspective of functional groups. Frontiers in Bioengineering and Biotechnology. 11. 1329311–1329311. 24 indexed citations
5.
Xu, Chuanli, et al.. (2023). Association between High-Sensitivity C-Reactive Protein and Blood Pressure Variability in Subacute Stage of Ischemic Stroke. Brain Sciences. 13(7). 998–998. 2 indexed citations
6.
Mu, Xiaopeng, et al.. (2022). Crosstalk between peripheral and the brain-resident immune components in epilepsy. Journal of Integrative Neuroscience. 21(1). 9–9. 9 indexed citations
7.
Xu, Chuanli, et al.. (2020). Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis. Cerebrovascular Diseases. 49(4). 442–450. 24 indexed citations
8.
Miao, Zhongrong, Yong Zhang, Jie Shuai, et al.. (2015). Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China. Stroke. 46(10). 2822–2829. 96 indexed citations
9.
Gao, Lianbo, et al.. (2014). Correlations of MCP-1 −2518A>G Polymorphism and Serum Levels with Cerebral Infarction Risk: A Meta-Analysis. DNA and Cell Biology. 33(8). 522–530. 9 indexed citations
10.
Gao, Lianbo, et al.. (2014). Genetic Polymorphisms in the ESR1 Gene and Cerebral Infarction Risk: A Meta-Analysis. DNA and Cell Biology. 33(9). 605–615. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026